Ovarian Stimulation 1st Edition Mohamed Aboulghar MD Download
Ovarian Stimulation 1st Edition Mohamed Aboulghar MD Download
download pdf
https://ebookfinal.com/download/ovarian-stimulation-1st-edition-mohamed-
aboulghar-md/
https://ebookfinal.com/download/regulators-of-ovarian-functions-1st-
edition-alexander-v-sirotkin/
https://ebookfinal.com/download/deep-brain-stimulation-1st-edition-
peter-bain/
https://ebookfinal.com/download/surgery-for-ovarian-cancer-3rd-ed-
edition-bristow/
https://ebookfinal.com/download/advanced-ceramic-processing-1st-
edition-adel-mohamed/
Vagus Nerve Stimulation 2nd Edition Steven C. Schachter
https://ebookfinal.com/download/vagus-nerve-stimulation-2nd-edition-
steven-c-schachter/
https://ebookfinal.com/download/deep-brain-stimulation-management-1st-
edition-william-j-marks-jr/
https://ebookfinal.com/download/altchek-s-diagnosis-and-management-of-
ovarian-disorders-3rd-edition-bachner/
https://ebookfinal.com/download/optoelectronic-devices-iii-
nitrides-1st-edition-mohamed-henini/
https://ebookfinal.com/download/transcranial-magnetic-stimulation-in-
clinical-psychiatry-1st-edition-mark-s-george/
Ovarian Stimulation 1st Edition Mohamed Aboulghar Md
Digital Instant Download
Author(s): Mohamed Aboulghar MD, Botros Rizk
ISBN(s): 9780521197359, 052119735X
Edition: 1
File Details: PDF, 13.05 MB
Year: 2011
Language: english
Ovarian Stimulation
Ovarian Stimulation
Edited by
Mohamed Aboulghar
Cairo University and The Egyptian IVF-ET Center
and
Botros Rizk
University of South Alabama
c a mb rid g e u n iv e r si t y pres s
Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore,
São Paulo, Delhi, Dubai, Tokyo, Mexico City
Published in the United States of America by Cambridge University Press, New York
www.cambridge.org
Information on this title: www.cambridge.org/9780521197359
A catalogue record for this publication is available from the British Library
Every effort has been made in preparing this book to provide accurate and up-to-date information
which is in accord with accepted standards and practice at the time of publication. Although case
histories are drawn from actual cases, every effort has been made to disguise the identities of the
individuals involved. Nevertheless, the authors, editors, and publishers can make no warranties that
the information contained herein is totally free from error, not least because clinical standards are
constantly changing through research and regulation. The authors, editors, and publishers therefore
disclaim all liability for direct or consequential damages resulting from the use of material contained
in this book. Readers are strongly advised to pay careful attention to information provided by the
manufacturer of any drugs or equipment that they plan to use.
To a dear friend, an honorable man, a legendary scientist, a Nobel Prize
winner and a world renowned leader.
To Professor Robert Geoffrey Edwards, the father of IVF and four million
babies worldwide.
We dedicate this book to you in gratitude for your friendship, mentorship
and leadership.
The world, East and West, has respected you, and we loved you and honored
you.
Contents
List of contributors page ix
About the editors xiii
Foreword by Alan H. De Cherney xv
Preface xvi
vii
Contents
Index 262
viii
Contributors
ix
List of contributors
x
List of contributors
xi
List of contributors
xii
About the editors
xiii
About the editors
USA. He is also Program Director and Medical and has edited and authored ten medical textbooks on
Scientific Director of the USA IVF and ART Program, ovarian hyperstimulation syndrome, infertility and
and Laboratory Director and Clinical Consultant at assisted reproduction, endometriosis, ultrasonog-
the Reproductive Endocrinology Laboratory of the raphy in reproductive medicine, ovarian stimulation
University of South Alabama. and the futue of ART.
Professor Rizk has worked as a research scien- He is past chair of the ASRM international mem-
tist and clinician in reproductive medicine for more bersip committee, member of the scientific advisory
than 25 years. His main research interests include the board of the Mediterranean Society for Reproductive
modern management, prediction and the genetics of Medicine, the editorial board of the Middle East Fertility
ovarian hyperstimulation syndrome (OHSS), as well Society Journal and reviewer for several national and
as the role of vascular endothelial growth factor and international journals, as well as for the European
interleukins in the pathogenesis of severe OHSS. He Society of Human Reproduction and Embryology Task
has authored more than 300 peer-reviewed published Force on perinatal outcome and congenital malforma-
papers, book chapters and abstracts. Professor Rizk tions of intracytoplasmic sperm injection.
xiv
Foreword
Alan H. DeCherney
National Institute of Child Health and HumM Development
Ovarian Stimulation is a text that is comprehensive, of novel agents in order to treat the entity, including
insightful, contains a great deal of new information, early aspiration of ascites.
and is well organized, making it easy to read. The book is Individual patient scenarios are also addressed,
divided into 6 sections and 23 chapters and is authored including polycystic ovarian syndrome and the “poor
by leaders in the field from the global community, with responder.” The discussion of the risk, benefits, and
representatives from such places as Canada, Europe, effectiveness of hCG versus LH is included. Of course,
the United States, Egypt, and Australia, to name a few. much of the data, application, and in-depth under-
The chapters evolve from ovarian stimulation standing come from the author’s experience with in
through procedures before, during, and after stimu- vitro fertilization (IVF), which is covered extensively
lation. Oral and injectable agents for ovulation induc- by looking at natural cycle IVF, in vitro maturation of
tion are discussed in great depth, incorporating a fair oocytes, as well as a more traditional approach.
amount of new material. In addition, therapies, such Techniques for monitoring, such as ultrasound and
as intrauterine insemination and laparoscopic ovarian serum estrodiol levels are also discussed in depth.
drilling are critically evaluated. The text is a comprehensive approach for under-
Ovarian Stimulation also addresses the utilization standing ovarian stimulation. There is no lack of infor-
of GnRH, for both solitary use in ovarian stimulation mation as far as this topic is concerned. It is up to date
and for use in combination with other agents. The with contemporary, excellent and established refer-
occasionally serious adverse effect of ovulation induc- ences. The book is a monumental contribution that
tion (i.e., desecrated hyperstimulation syndrome), is enriches our knowledge about a very important topic
looked at in terms of the diagnosis therapy and the use in reproductive endocrinology and infertility.
xv
Preface
Ovarian stimulation has become an integral part of the The book covers in its different sections and chap-
management of infertility and assisted reproduction. A ters all aspects of ovarian stimulation: the different
glance through scientific journals would demonstrate stimulation protocols from which to choose, the man-
an explosion of publications related to ovarian stimula- agement of poor responders and hyper-responders,
tion. In every world congress and international infertil- triggering ovulation and luteal phase support.
ity meeting the ovarian stimulation session is the most We have thoroughly enjoyed putting this book
popular and lively session of the entire meeting. together and we take this opportunity to thank all
This book was authored by the world leaders in the authors for their friendship and most valuable
infertility and reproductive endocrinology from the contributions.
United States, Canada, Europe, Australia, the Middle To our readers, we put into your hands a concise
East, and Africa. Each contributor has been the pioneer and global book that we hope that you will thoroughly
of the respective area of clinical research and practice. enjoy.
xvi
Section 1 Mild forms of ovarian stimulation
Chapter
Ovarian stimulation aims at the development of one pituitary gonadotropins in 1958, and the first preg-
or more of the ovarian follicles to reach the stage of nancy was reported two years later [1;2]. One year later,
maturity culminating in the release of one or more in 1961, Bettendorf and his group reported a similar
mature oocytes ready for fertilization. Ovarian follicu- experience [3]. In the same year, Greenblatt and his co-
lar development is under the control of local factors workers published the first results of ovarian stimula-
inside the ovaries (most of it is poorly understood), as tion by an oral agent called at that time MRL/41, later
well as hormones produced from extraovarian sources, known as clomiphene citrate [4]. Over the last two
mainly pituitary gonadotropins. Other hormones may decades, insulin sensitizers have been introduced into
play a role in ovarian follicular development; the extent clinical practice for ovulation induction in polycystic
and details of such a role are not fully understood. ovary syndrome (PCOS) patients with significant insu-
There are two mechanisms for ovarian stimula- lin resistance. The last decade introduced the success
tion: the first involves applying pharmacological agents of a new group of oral agents for ovarian stimulation,
that mimic endogenous gonadotropins (injectable the aromatase inhibitors. The aromatase inhibitor,
gonadotropins) that directly stimulate ovarian follicu- letrozole has been suggested as an alternative to clomi-
lar development through gonadotropin receptors. The phene citrate as an agent for ovulation induction and
second involves pharmacological agents that manipu- to improve the outcome of controlled ovarian stimu-
late and moderate endogenous gonadotropin produc- lation with gonadotropins. In 2000, we presented the
tion. Those agents are oral ovulation induction agents first report in the literature on the success of letrozole
that are believed to stimulate ovulation through moder- in inducing ovulation in anovulatory women with
ating estrogen action, a major regulator of endogenous PCOS [5].
gonadotropin production. This chapter reviews those
agents with a focus on the clinical aspects of their use. Clomiphene citrate
There are two groups of pharmacological agents For more than half a century, clomiphene citrate (CC)
for ovarian stimulation: the first group includes inject- has been the most commonly used agent for ovarian
able gonadotropins and the second group includes oral stimulation. Interestingly, since first reports in the
agents that are estrogen modulators. Oral agents modu- early 1960s, results of CC treatment (ovulation and
late estrogen action, and hence endogenous gonado- pregnancy rates) have not changed appreciably, des-
tropin production through a direct effect on estrogen pite the advent of modern immunoassays for steroid
receptors, i.e., selective estrogen receptor modulators hormones, advances in ultrasound technology for
(SERMs), or through modulation of estrogen produc- cycle monitoring, and the introduction of commercial
tion (inhibition), i.e., aromatase inhibitors, or inhibi- ovulation predictor kits that allow accurate identifica-
tors of the estrogen synthesis enzyme (the aromatase tion of the mid-cycle LH surge. It has been puzzling
enzyme). Clomiphene citrate is the most commonly that CC use has continued all those years as an ovar-
used and known SERM and letrozole is the most com- ian stimulation agent despite the fact that CC citrate is
monly used and known aromatase inhibitor. known as a pregnancy risk category X. This is particu-
The first successful ovarian stimulation case was larly important when considering the relatively long
reported by Gemzell and his co-workers using human half-life of about 5–21 days (depending on the isomer).
Ovarian Stimulation, ed. Mohamed Aboulghar and Botros Rizk. Published by Cambridge University Press. © Cambridge
University Press 2011.
1
Section 1: Mild forms of ovarian stimulation
Moreover, CC can be stored in body fat. Those facts levels, i.e. estrogen concentrations are falsely perceived
allow CC to accumulate in the body around crucial as low leading to reduced estrogen negative feedback
times of implantation, organogenesis, and embryo- on GnRH production by the hypothalamus and gona-
genesis [6–8]. dotropins (FSH and LH) by the pituitary. During CC
treatment, levels of both LH and FSH rise, then fall
Chemical structure and pharmacokinetics again after the typical 5-day course of therapy is com-
pleted. In successful treatment cycles, one or more
Clomiphene citrate is a nonsteroidal triphenylethyl-
dominant follicles emerge and mature, generating a
ene derivative that exhibits both estrogen agonist and
rising tide of estrogen that ultimately triggers the mid-
antagonist properties, i.e. selective estrogen receptor
cycle LH surge and ovulation [9;10]. It is important to
modulator. Estrogen agonist properties are manifest
stress the two main prerequisites for the success of CC
only when endogenous estrogen levels are extremely
ovarian stimulation: presence of reasonable estrogen
low. Otherwise, CC acts mainly as an antiestrogen [6].
levels in the body and an intact hypothalamic/pituitary
Clomiphene citrate is a racemic mixture of two distinct
axis capable of producing endogenous gonadotropins.
stereoisomers, enclomiphene and zuclomiphene, hav-
ing different properties. Enclomiphene is the more
potent antiestrogenic isomer and the one primarily Regimens of clomiphene citrate
responsible for the ovulation-stimulation actions of administration for ovarian stimulation
CC [6–8]. Enclomiphene has a half-life of few days Clomiphene citrate regimens for ovarian stimulation
while the other isomer, zuclomiphene, is cleared far usually start on the 2nd to 5th day after the onset of
more slowly with levels detectable in the circulation for spontaneous or progestin-induced menses. Treatment
more than one month after treatment and may actu- typically begins with a single 50 mg tablet daily for 5
ally accumulate over consecutive treatment cycles [8]. consecutive days, increasing by 50 mg increments in
Clomiphene citrate is cleared through the liver and subsequent cycles until ovulation is induced. Once the
excreted in the stool. About 85 percent of an admin- effective dose of CC for ovarian stimulation is estab-
istered dose is eliminated after approximately 6 days, lished, there is no indication for further increments
although traces may remain in the circulation for much unless the ovulatory response is lost, i.e. higher doses
longer [7]. will not improve the probability of pregnancy. The day
of starting CC treatment has not been shown to affect
Mechanism of action the ovulation rates, conception rates, or pregnancy
Clomiphene citrate’s structural similarity to estrogen outcome in anovulatory women.
allows it to bind to estrogen receptors (ER) throughout The dose required for achieving ovulation is cor-
the body. Such binding lasts for an extended period of related with body weight. However, there is no reliable
time, up to weeks rather than hours as is the case with way to predict what dose will be required in an individ-
natural estrogen. Such extended binding ultimately ual woman. Although the effective dose of CC ranges
depletes ER concentrations by interfering with the nor- from 50 to 250 mg/day, lower doses (e.g. 12.5 to 25 mg/
mal process of ER replenishment [4]. day) may be tried in some women who are very sen-
It is believed that the hypothalamus is the main site sitive to CC. Most women respond to treatment with
of action because in normally ovulatory women, CC 50 mg (52%) or 100 mg (22%). Although higher doses
treatment was found to increase gonadotropin-releas- are sometimes required, the success rates are usually
ing hormone (GnRH) pulse frequency [9]. However, very low (150 mg, 12%; 200 mg, 7%; 250 mg, 5%). Most
actions at the pituitary level may also be involved since women who fail to respond to 150 mg of CC will ulti-
CC treatment increased pulse amplitude, but not fre- mately require alternative or combination treatments
quency in anovulatory women with polycystic ovar- [11;12].
ian syndrome, in whom the GnRH pulse frequency Pregnancy rates are highest in the early cycles of CC
is already abnormally high [10]. The antiestrogenic treatment (first three cycles) with a significant decline
effect on the hypothalamus, and possibly the pituit- in the chance of achieving pregnancy beyond the third
ary, is believed to be the main mechanism of action for treatment cycle down to a very low chance beyond the
ovarian stimulation. Depletion of hypothalamic ER sixth treatment cycle. For that reason, it is not advisable
prevents correct interpretation of circulating estrogen to continue CC treatment beyond six treatment cycles
2
Chapter 1: Oral agents for ovarian stimulation
[11]. It is important to mention here that the above soon after treatment ends. Other important side effects
mentioned data come from studies in anovulatory include visual disturbances, e.g. blurred or double
women when CC was used to induce ovulation. On the vision, scotomata, and light sensitivity are generally
other hand, the value of CC treatment in enhancing the uncommon (<2% prevalence) and reversible. However,
chance of achieving pregnancy in cases with ovulatory there are isolated reports of persistent symptoms long
infertility has been questioned [12]. after treatment is discontinued, with more severe com-
plications such as optic neuropathy. Those visual side
Outcome of clomiphene citrate ovarian effects are contraindication for the use of CC that war-
rants stopping treatment and considering alternative
stimulation methods of ovarian stimulation. Other fairly common
In anovulatory women with WHO Type II anovula- but less serious side effects include breast tenderness,
tion, CC has been reported to induce ovulation in 60% pelvic discomfort, and nausea, all observed in 2% to 5%
to 80% of patients with almost two-thirds responding of CC-treated women [14]. In addition, we have noted
to 50 mg or 100 mg dosage levels. After up to three ovu- relatively common reports of premenstrual syndrome-
latory cycles, cumulative conception was encountered type symptoms in women on clomiphene citrate [15].
in a little less than two-thirds of patients (about 60%).
Up to 85% pregnancy rate has been reported after five Multiple-gestation pregnancy
ovulatory cycles with fecundity of about 15% in ovu-
With clomiphene, citrate ovarian stimulation multi-
latory cycles [11]. It is important to realize that these
follicular development is relatively common, which
figures were reported in anovulatory, young women
increases the risk of multiple gestation, reported to be
in whom anovulation was the sole infertility factor.
approximately 8%. However, the overwhelming major-
Interestingly, amenorrheic women are more likely to
ity of multiple gestations that result from CC treatment
conceive than oligomenorrheic women after CC ovar-
are twins. Triplet and higher-order pregnancies are
ian stimulation. This is probably because those who
rare [16]. Several studies have shown that the number
already ovulate, albeit inconsistently (oligomenor-
of multiple-gestation pregnancies can be decreased by
rheic), are more likely to have other coexisting infer-
the more judicious use of ovarian stimulation agents
tility factors. Generally speaking, failure to conceive
and by increased monitoring [17;18].
within six ovulatory cycles of CC treatment should be
regarded as a clear indication to expand the diagnos-
tic evaluation to exclude other infertility factors or to
Severe ovarian hyperstimulation syndrome
change the overall treatment strategy when evaluation The incidence of severe ovarian hyperstimulation syn-
is already complete [13]. drome (OHSS) after clomiphene citrate treatment is dif-
ficult to determine, as definitions of the syndrome vary
widely among studies. Mild OHSS (moderate ovarian
Adverse effects and drawbacks of enlargement) is relatively common, but also does not
clomiphene citrate treatment require active management. When CC induction of
Clomiphene citrate is in general a safe medication and ovulation proceeds in the recommended incremental
usually well tolerated, with most of the side effects being fashion designed to establish the minimum effective
relatively mild. Side effects are rarely severe enough dosage, the risk of severe OHSS is remote [13].
to prevent continuation of treatment. Side effects are
generally divided into those related to medication Ovarian cancer
itself and other side effects that are related to ovarian There is an uncertain association of ovarian cancer
stimulation in general, such as ovarian hyperstimula- with clomiphene citrate treatment that has been sug-
tion syndrome and multiple gestation. Other serious gested by two epidemiologic studies published early in
long-term adverse effects of CC treatment have been the last decade. The first was a case-control study con-
suggested, including increased risk of ovarian cancer. cluding that ovarian cancer risk was increased nearly
Hot flashes, the most common side effect occur- threefold overall in women receiving various infer-
ring in about 10% of all women, is due to the antiestro- tility treatments including CC [19]. The study meth-
genic property of CC and seems to be dose-dependent. odology had several problems. The study compared
They are transient, rarely severe, and typically resolve infertile treated women to fertile women rather than to
3
Section 1: Mild forms of ovarian stimulation
infertile untreated women, even though infertility and losses were increased by CC treatment (5.8% vs. 3.9%,
nulliparity have long been recognized as risk factors P < 0.01) and for age > or = 30 years (8.0% vs. 4.9%,
for ovarian cancer. In addition, there was no apparent P < 0.001), but not for age < 30 years (3.7% vs. 3.0%).
increase in ovarian cancer risk in treated women who Clinical miscarriages were increased by CC for women
conceived. The second study was a cohort study con- younger than 30 years (15.9% vs. 11.2%) (P < 0.01), but
cluding that risk of ovarian tumors was increased in not for age > or = 30 years (20.1% vs. 22.3%) or overall
women treated with CC [20]. Comparisons within the (18.0% vs. 16.4%) [34].
CC ovarian stimulation cohort showed no increase in A more recent study looking at rates of spontaneous
risk with fewer than 12 cycles of treatment. This study miscarriage in 62 228 clinical pregnancies resulting
too was widely criticized, primarily because it included from assisted reproductive technology procedures ini-
cancers of varying types and tumors of low malignant tiated in 1996–1998 in US clinics, also found that spon-
potential (e.g. epithelial, germ cell, stromal), where the taneous miscarriage risk was increased among women
pathophysiology of each is likely very different. who used CC [35]. However, the results of these studies
The results of subsequent studies have been reassur- are not definitive. Pregnancy loss after infertility treat-
ing, but the question of whether treatment with ovula- ment is a complex matter, influenced by several signifi-
tion-inducing drugs increases risk of ovarian tumors cant confounding factors such as insulin resistance and
or cancer remains unsettled and cannot be summarily other genetic factors related to PCOS, the presence of
dismissed [21–28]. endometriosis or unexplained infertility, and advan-
cing maternal age [36].
Congenital anomalies
There is no evidence that clomiphene citrate treatment Failure of clomiphene citrate treatment
increases the overall risk of birth defects or of any spe-
In anovulatory infertility, clomiphene citrate treat-
cific malformation. Several large series have examined
ment failure is defined into two groups. The first group,
the question and have drawn the same conclusion
ovulation failure (clomiphene resistance), includes
[29;30]. Earlier suggestions that the incidence of neural
patients who fail to ovulate in response to CC ovarian
tube defects might be higher in pregnancies conceived
stimulation. The second group, clomiphene pregnancy
during CC treatment have not been confirmed by more
failure, includes patients who ovulate in response to
recent studies [31]. A small study of pregnancy outcome
CC ovarian stimulation but fail to achieve pregnancy.
in women inadvertently exposed to CC during the first
This second group also includes women with ovulatory
trimester also found no increase in the prevalence of
infertility who failed to achieve pregnancy after CC
congenital anomalies [32]. However, most recently,
treatment.
an increase in the risk of congenital malformations
Clomiphene citrate resistance (failure to achieve
of the heart has been suggested, though the study was
ovulation) is believed to be due to one of two main
not designed or powered to answer that question and
reasons: insulin resistance (women with PCOS) and
further studies are needed to confirm or negate such a
inappropriate indication for CC treatment, e.g. use
finding [33].
in women with WHO Type I or III anovulation or
women with ovulatory dysfunction due to medical
Pregnancy loss disorders that require specific treatments such as thy-
A fairly large study reviewed outcomes of 1744 clomi- roid disorders, congenital adrenal hyperplasia, and
phene pregnancies compared with outcomes of 3245 hyperprolactinemia.
spontaneous pregnancies. Pregnancy loss was defined The reasons for clomiphene pregnancy failure
as clinical if a sac was seen on ultrasound or if it (women who ovulate in response to CC ovarian stimu-
occurred after 6 weeks’ gestation, and as preclinical if lation but do not achieve pregnancy) may be related to
a quantitative human chorionic gonadotropin (hCG) a wide variety of underlying infertility factors such as
was > or = 25 IU/L and no sac was seen or pregnancy male factor, endometriosis, undiagnosed tubal factor,
loss occurred earlier. The overall incidence of preg- or endometrial receptivity factors. However, the suc-
nancy loss was slightly higher, but not significant, for cess of many of these women in achieving pregnancy
clomiphene pregnancies (23.7%), compared with spon- with alternative ovarian stimulation protocols using
taneous pregnancies (20.4%). Preclinical pregnancy injectable gonadotropins or aromatase inhibitors
4
Random documents with unrelated
content Scribd suggests to you:
per cent that high-school attendance was of total attendance; (5) per
cent that boys were of girls in high schools; (6) average annual
expenditure per child attending; (7) average annual expenditure per
child of school age; (8) average annual expenditure per teacher
employed; (9) expenditure per pupil for purposes other than
teachers’ salaries: and (10) expenditure per teacher for salaries. The
publication includes tables giving the index numbers of the several
states for the census years since 1890 and for 1918, the resulting
ranks of the states at the several periods, the correlation between the
several items and the final index, and the correlation between the
average of the five items that are based on attendance and the
average of the five that are based on expenditure.”—School R
Reviewed by J: B. Andrews
“In this book the statistician of Wellesley Hills holds that we must
look to religion and not to modern efficiency methods to insure
national prosperity. He contends that down to this hour, mankind
(or humanity—or the world at large) has lost its way, chiefly because
of its refusal to accept the golden rule as the basis of true living.”—
Springf’d Republican
“It is a little hard to tell where Babson begins and Wilson leaves
off, for the biographer has not been quite able to play the part of
Boswell to his Johnson.” J. E. Le Rossignol
“Mr Babson has both succeeded and failed. He has done effectively
what he set out to do. He has failed to do the much greater thing,
such for example, as that which Graham Wallas has accomplished in
his life of Francis Place. In a word, his book is not a biography
insofar as biography is an art.” W. L. C.
“The pathos and humor of the play seem dry and forced in the
story. Still the charm of old ‘Lightnin’ Bill’ Jones stands to some
extent.”
“At Dover during 1915, 1916 and 1917, more operations were
initiated and carried out than under any naval command since the
wars at the beginning of last century.” (Preface) The author
enumerates his reasons for writing the book: to write while memory
is still accurate; to fill the need for an adequate account of the work
of the Dover patrol; to contradict the untrue statements of the press
anent his dismissal. Contents of volume 1: Historical; The ships of
the Dover patrol; Matters of strategy; Coastal bombardments; The
work of the trawlers and paddle mine-sweepers; The Belgian coast,
its patrol and barrages; Landing the guns on the Belgian coast; A
proposed attack on Ostend; Preparations for a great landing; Plans
for blocking Zeebrugge and Ostend; The control and protection of
traffic. Contents of volume 2: The incomparable sixth flotilla; The
downs and merchant shipping; The barrages in the channel; The
drifters and their tasks; The French coast; C.M.B.’s, M.L.’s,
submarines and smoke; Operations; The air services of the Dover
patrol; Dover harbour and dockyard; Epilogue; Appendixes; Index.
Each volume is abundantly illustrated and supplied with charts and
diagrams.
“Admiral Bacon’s book has in it much matter for the layman and
much for the expert. For that reason it is more shapeless than have
been many books written about the war. For that reason also, it is a
truer presentment of the conditions obtaining.” Muriel Harris
“The 633 pages of ‘The Dover patrol’ are crowded with statements
of fact, criticisms not indeed of persons (for, apart from his official
enemy, and vague indications of contradicting sinners, Admiral
Bacon is generous in his tone to his colleagues and subordinates),
but of principles and the methods of the art of war at sea. Admiral
Bacon sometimes writes expressly for the professional reader, but he
remembers the little knowledge of most of us, avoids pedantry, and
has a respectable share of the blessed faculty for making things
clear.”
“A readable handbook.”
+ Booklist 17:9 O ’20
+ Review 3:215 S 8 ’20 80w
All the well-known myths are here retold for boys and girls. There
is an introduction on How the myths began, followed by the stories
of Prometheus, Pandora (Hawthorne’s “Paradise of children”),
Vulcan, Orion, Perseus, Pegasus, Phaeton, Apollo, Mercury,
Proserpine, Jason, the golden apples, the wooden horse, and others.
There are six pictures in color by Clara M. Burd.
“An attractive collection.”
“Throughout the book the action never lags; there are no dull
moments. As a spy-story having an historic background and
interwoven with a charming love affair, ‘Barry Leroy’ is above the
average in construction and sustained interest.”
“Her readers will like this new book. The love passages are
wholesome, strike the note of sincerity, and therefore cannot but be
acceptable.”
The author disclaims all responsibility for his stories which he says
come to him “suddenly, like a flash of lightning all together.... I never
know, the day before, when one is coming: it arrives, as if shot out of
a pistol.” (Introd.) This exotic Hindu tale is half love-story, half fairy
tale, and depicts in the extraordinary queen, Táráwalí, a being half
male half female. It is in three parts: On the banks of Ganges; The
heart of a woman; and A story without an end.
Reviewed by H. W. Boynton
“Those who have read Mr Bain’s other Hindu stories will not need
to be told of the unique place he now occupies in the world of letters.
Here the exigencies of space will permit us to say only that ‘The
substance of a dream’ is a worthy successor to the other and earlier
volumes.”
“You cannot say whether his style is artful or artless; but the words
make new associations for us, create an unfamiliar state of being,
though they are familiar words.”
[2]
BAIRNSFATHER, BRUCE. Bairnsfather case;
as tried before Mr Justice Busby; defence by Bruce
Bairnsfather; prosecution by W. A. Mutch. il *$2.50
Putnam 827
20–21304
“It has that satirical note without which a whole book of humour is
apt to be sticky reading.”
“All the plays collected here are significant—all have added to the
pleasure of playgoing. This book makes their remembrance the
richer.” W. S. B.
“Four out of the five at least have interesting stories, and are
flawless in their adaptation to the theatre; but gayly as they trip on
the stage, they drag a little in the reading.”
+ − Review 3:389 O 27 ’20 350w
“The poems have been written ‘at intervals since 1901,’ the author
says, and consequently their moods are various.” (Springf’d
Republican) “Love, children, the cause of woman all move her to
song. Among other pieces we have specially noted the well-handled
conceit called ‘Winter secrets’; the happy introspective fancy called
‘The lost one’; the truly heartfelt elegy for ‘The dead fore-runner’ of
the woman’s movement; and the delightful literary reverie called
‘The love of Elia.’” (The Times [London] Lit Sup)
“These poems are not all smoke. There are many glowing embers
and a few blazing coals. Mrs Baker shows something of antique
restraint and not a little of the newer and freer impulse.” C. M.
Greene
+ Bookm 50:634 F ’20 140w
“Each is not only well chosen for its primary purpose of use in
engineering schools but might also be read, or read anew, by
engineers in practice.”
“It strikes a reader that these addresses, each advocating the claim
of some one branch of science, interesting as they are, would have
been more useful if there had been a recognition of the distinction
between what should be included in the school course preceding the
technical course, in the technical course itself necessarily restricted,
and what extra academic self-education should be expected to
accompany and follow it.” W. C. U.
“Combining the lucidity of the trained writer, the quick eye of the
reporter and the orderly reflectiveness of the born philosopher, Mr
Baker’s birdseye view of what is wrong with American industry is the
best book of its kind which has yet appeared.”
Reviewed by J. E. Le Rossignol
Our website is not just a platform for buying books, but a bridge
connecting readers to the timeless values of culture and wisdom. With
an elegant, user-friendly interface and an intelligent search system,
we are committed to providing a quick and convenient shopping
experience. Additionally, our special promotions and home delivery
services ensure that you save time and fully enjoy the joy of reading.
ebookfinal.com